Block deals: Four stocks see large trades worth over ₹2,000 crore on Tuesday; Check how they reacted

Shares of Ajanta Pharma, Emcure Pharmaceuticals, Capital Small Finance Bank and BlueStone Jewellery witnessed large block deals on Tuesday, June 9, with transactions worth more than ₹2,000 crore taking place during the block deal window.

While shares of Bluestone Jewellery are trading with losses, the other three names are trading with gains between 1% to 3%.

Ajanta Pharma Block Deal

Around 34.5 lakh shares of Ajanta Pharma, worth nearly ₹1,024 crore changed hands in a block deal. The transaction was executed at ₹2,968 per share.

The shares exchanged represent nearly 2.8% of the company's outstanding equity.

As of the March 2026 quarter, promoters held a 66.25% stake in Ajanta Pharma, while public shareholders owned 33.75%. Mutual funds held 15.2% of the company, with UTI Flexi Cap Fund being the largest mutual fund shareholder at 3.19%, followed by Nippon India Small Cap Fund at 2.84%.

The identities of the buyers and sellers were not immediately known.

Also read: Emcure Pharmaceuticals

Emcure Pharmaceuticals Block Deal

In Capital Small Finance Bank

, 36 lakh shares changed hands through a block deal worth ₹612 crore at an average price of ₹1,700 per share.

The transaction represents about 1.9% of the company's equity base.

Promoters held a 77.87% stake in Emcure as of March 2026, while public shareholders owned 22.13%. Among notable public shareholders, BC Investments IV Ltd held a 3.87% stake, while Nippon India Multi Cap Fund owned 1.95%.

Capital Small Finance Bank Block Deal

Shares worth nearly ₹37 crore changed hands in BlueStone Jewellery through a block deal involving 13.62 lakh shares at ₹270 apiece.

The deal size corresponds to roughly 3% of the bank's outstanding equity.

Promoters owned 18.01% of the lender at the end of the March quarter, while public shareholders held nearly 82%. Major institutional investors include Oman India Joint Investment Fund II (5.53%), ICICI Prudential Life Insurance (3.67%), Edelweiss Life Insurance (3.53%) and SIDBI (2.97%).

BlueStone Jewellery Block Deal

BlueStone Jewellery saw the largest volume transaction among the four, with 67.6 lakh shares changing hands via block deals. The shares account for about 4.4% of the company's equity capital.

At the average price of ₹527 per share, the total transaction value could be nearly ₹356 crore.

As of March 2026, promoter shareholding stood at 16.27%, while public shareholders held 83.73%.

Among key shareholders, Accel India III (Mauritius) owned 8.73%, SBI Life Insurance held 5%, Nippon India Trustee-owned funds held 4.03%, while investors such as Peak XV Partners, Kalaari Capital, Iron Pillar and IvyCap Ventures also held meaningful stakes.

Stock Price Reaction

Shares of Bluestone Jewellery are trading 5.2% lower on Tuesday at ₹520.65.

Shares of Ajanta Pharma are trading 1.7% higher on Tuesday at ₹3,018.8.

Capital Small Finance Bank shares are off their opening highs, currently trading 1.2% higher at ₹271.4.

Shares of Emcure Pharma are outperforming the block deal bunch, trading 3.6% higher at ₹1,781.4.